We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
-5.25%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$578B
AUM Growth
-$88.6B
Cap. Flow
+$4.3B
Cap. Flow %
0.74%
Top 10 Hldgs %
34.17%
Holding
14,706
New
1,657
Increased
4,873
Reduced
6,001
Closed
1,835

Sector Composition

Rank Sector Weight
1 Miscellaneous 91.96%
2 Technology 2.07%
3 Consumer Discretionary 1.49%
4 Financials 1.12%
5 Communication Services 1.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TK icon
12201
CALL
Teekay
TK
$1.14B
$53K ﹤0.01%
16,700
-27,000
-62% -$87.4K
TROO icon
12202
PUT
TROOPS Inc
TROO
$263M
$53K ﹤0.01%
12,400
-66,800
-84% -$291K
UAVS icon
12203
PUT
AgEagle Aerial Systems
UAVS
$67.9M
$53K ﹤0.01%
45
-33
-42% -$39K
XFOR icon
12204
PUT
X4 Pharmaceuticals
XFOR
$401M
$53K ﹤0.01%
1,013
-1,744
-63% -$100K
TIG
12205
CALL
DELISTED
Trean Insurance Group, Inc. Common Stock
TIG
$53K ﹤0.01%
+11,300
New +$76.2K
FNHC
12206
DELISTED
FedNat Holding Company Common Stock
FNHC
$53K ﹤0.01%
39,265
-6,196
-14% -$8.28K
FTEK icon
12207
CALL
Fuel Tech
FTEK
$46.2M
$52K ﹤0.01%
35,700
+3,600
+11% +$4.6K
GSIT icon
12208
PUT
GSI Technology
GSIT
$219M
$52K ﹤0.01%
13,600
+3,000
+28% +$12.9K
MREO
12209
CALL
Mereo BioPharma
MREO
$40.3M
$52K ﹤0.01%
+46,200
New +$59.7K
VINC
12210
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$52K ﹤0.01%
+655
New +$80.9K
ITI
12211
DELISTED
Iteris, Inc.
ITI
$52K ﹤0.01%
17,572
-18,148
-51% -$62.9K
GENE
12212
CALL
DELISTED
Genetic Technologies Ltd.
GENE
$52K ﹤0.01%
5,260
-260
-5% -$2.53K
CNCE
12213
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$52K ﹤0.01%
+15,476
New +$49.1K
DYAI icon
12214
CALL
Dyadic International
DYAI
$24.6M
$51K ﹤0.01%
+17,000
New +$63.7K
OTRK
12215
CALL
DELISTED
Ontrak
OTRK
$51K ﹤0.01%
251
-1,658
-87% -$452K
VHC icon
12216
VirnetX Holding Corp
VHC
$51.1M
$51K ﹤0.01%
1,570
-15,307
-91% -$625K
ZEPP
12217
Zepp Health
ZEPP
$73.9M
$51K ﹤0.01%
4,456
-3,123
-41% -$50.4K
AFIB
12218
PUT
DELISTED
Acutus Medical Inc
AFIB
$51K ﹤0.01%
36,500
-8,100
-18% -$17.3K
DBTX
12219
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$51K ﹤0.01%
16,846
-22,580
-57% -$86.5K
INFI
12220
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$51K ﹤0.01%
45,053
-150,026
-77% -$179K
LTCH
12221
CALL
DELISTED
Latch, Inc. Common Stock
LTCH
$51K ﹤0.01%
+11,900
New +$62.2K
WEJO
12222
PUT
DELISTED
Wejo Group Limited Common Shares
WEJO
$51K ﹤0.01%
+12,500
New +$54.2K
CNCE
12223
PUT
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$51K ﹤0.01%
15,200
-10,600
-41% -$33.6K
ELMS
12224
PUT
DELISTED
Electric Last Mile Solutions, Inc. Class A Common stock
ELMS
$51K ﹤0.01%
35,600
-68,200
-66% -$222K
FABC
12225
PUT
Fabric.AI Inc
FABC
$18.8M
$50K ﹤0.01%
304
-432
-59% -$71.4K

Similar funds

Jeff Yass's Q1 2022 Portfolio in Review

As of Q1 2022, Jeff Yass held 14,706 positions worth $578B, down 13% from $667B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Jeff Yass's Q1 2022 filing shows 1,657 new, 4,873 increased, 6,001 reduced and 1,835 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 1,089,723 shares worth $107M. The largest sale was Walt Disney, an estimated $498M.

By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, down from 93% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q1 2022 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 1,089,723 shares worth $107M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $1.98B increase.
  • Jeff Yass's biggest Q1 2022 reduction was Walt Disney, cutting an estimated $498M.
  • Jeff Yass fully exited Xilinx Inc in Q1 2022, selling an estimated $217M.
  • Jeff Yass's ten largest holdings make up 34% of its $578B portfolio in Q1 2022.
  • Jeff Yass opened 1,657 new positions and closed 1,835 in Q1 2022.
  • Jeff Yass's portfolio value fell 13% quarter-over-quarter to $578B.

Based on Susquehanna International Group's 13F filing for Q1 2022, filed 16 May 2022.